- Home
- HQI vs ACHV Comparison
HQI vs ACHV Comparison
Compare HQI & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HQI
- ACHV
- Stock Information
- Founded
- HQI 2002
- ACHV N/A
- Country
- HQI United States
- ACHV Canada
- Employees
- HQI N/A
- ACHV N/A
- Industry
- HQI Professional Services
- ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- HQI Consumer Discretionary
- ACHV Health Care
- Exchange
- HQI Nasdaq
- ACHV Nasdaq
- Market Cap
- HQI 172.8M
- ACHV 159.0M
- IPO Year
- HQI N/A
- ACHV N/A
- Fundamental
- Price
- HQI $14.01
- ACHV $4.47
- Analyst Decision
- HQI Strong Buy
- ACHV Strong Buy
- Analyst Count
- HQI 2
- ACHV 3
- Target Price
- HQI $18.00
- ACHV $14.00
- AVG Volume (30 Days)
- HQI 14.9K
- ACHV 87.7K
- Earning Date
- HQI 11-06-2024
- ACHV 11-07-2024
- Dividend Yield
- HQI 1.71%
- ACHV N/A
- EPS Growth
- HQI N/A
- ACHV N/A
- EPS
- HQI 0.37
- ACHV N/A
- Revenue
- HQI $36,133,000.00
- ACHV N/A
- Revenue This Year
- HQI N/A
- ACHV N/A
- Revenue Next Year
- HQI $7.62
- ACHV N/A
- P/E Ratio
- HQI $37.80
- ACHV N/A
- Revenue Growth
- HQI 3.96
- ACHV N/A
- 52 Week Low
- HQI $11.39
- ACHV $3.03
- 52 Week High
- HQI $17.31
- ACHV $5.98
- Technical
- Relative Strength Index (RSI)
- HQI 52.46
- ACHV 51.93
- Support Level
- HQI $13.46
- ACHV $4.23
- Resistance Level
- HQI $14.79
- ACHV $4.64
- Average True Range (ATR)
- HQI 0.54
- ACHV 0.16
- MACD
- HQI -0.00
- ACHV 0.03
- Stochastic Oscillator
- HQI 45.83
- ACHV 69.43
About HQI HireQuest Inc. (DE)
HireQuest Inc is a nationwide franchisor of offices providing direct-dispatch, executive search, and commercial staffing solutions in the light industrial and blue-collar segments of the staffing industry and traditional commercial staffing. The company's franchisees provide various types of temporary personnel through two business models operating under the trade names HireQuest Direct, HireQuest, Snelling, DriverQuest, HireQuest Health, Northbound Executive Search, and MRI. The primary source of revenue for the company is royalty fees based on the operation of its franchised offices.
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.